SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-039789
Filing Date
2023-05-15
Accepted
2023-05-15 16:16:14
Documents
50
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_hoththerap.htm   iXBRL 10-Q 424181
2 CERTIFICATION f10q0323ex31-1_hoththerap.htm EX-31.1 11318
3 CERTIFICATION f10q0323ex31-2_hoththerap.htm EX-31.2 11423
4 CERTIFICATION f10q0323ex32-1_hoththerap.htm EX-32.1 4059
5 CERTIFICATION f10q0323ex32-2_hoththerap.htm EX-32.2 3868
  Complete submission text file 0001213900-23-039789.txt   3291412

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hoth-20230331.xsd EX-101.SCH 46514
7 XBRL CALCULATION FILE hoth-20230331_cal.xml EX-101.CAL 20823
8 XBRL DEFINITION FILE hoth-20230331_def.xml EX-101.DEF 189847
9 XBRL LABEL FILE hoth-20230331_lab.xml EX-101.LAB 386963
10 XBRL PRESENTATION FILE hoth-20230331_pre.xml EX-101.PRE 205818
44 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_hoththerap_htm.xml XML 292764
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38803 | Film No.: 23922611
SIC: 2834 Pharmaceutical Preparations